VMA21 and colorectal carcinoma: In patients receiving chemotherapy, the expression of VMA21 in CRC was marginally (P = 0.062) associated with DSS in stage II disease, whereas the association was not significant in patients who did not receive chemotherapy (P = 0.52) (Supplementary Figure 3).